MCF Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-100
| Closed | -$10K | – | 497 |
|
|
2019
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 368 |
|
|
2019
Q2 | $9K | Hold |
100
| – | – | ﹤0.01% | 361 |
|
|
2019
Q1 | $9K | Sell |
100
-400
| -80% | -$35K | ﹤0.01% | 356 |
|
|
2018
Q4 | $32K | Hold |
500
| – | – | 0.01% | 249 |
|
|
2018
Q3 | $45K | Hold |
500
| – | – | 0.01% | 223 |
|
|
2018
Q2 | $40K | Sell |
500
-95
| -16% | -$7.89K | 0.01% | 231 |
|
|
2018
Q1 | $53K | Buy |
595
+500
| +526% | +$48K | 0.01% | 211 |
|
|
2017
Q4 | $10K | Hold |
95
| – | – | ﹤0.01% | 339 |
|
|
2017
Q3 | $14K | Hold |
95
| – | – | ﹤0.01% | 322 |
|
|
2017
Q2 | $12K | Hold |
95
| – | – | ﹤0.01% | 356 |
|
|
2017
Q1 | $12K | Hold |
95
| – | – | ﹤0.01% | 345 |
|
|
2016
Q4 | $11K | Sell |
95
-31
| -25% | -$3.45K | ﹤0.01% | 310 |
|
|
2016
Q3 | $13K | Sell |
126
-700
| -85% | -$75.8K | ﹤0.01% | 304 |
|
|
2016
Q2 | $81K | Buy |
826
+731
| +769% | +$75.6K | 0.02% | 177 |
|
|
2016
Q1 | $10K | Hold |
95
| – | – | ﹤0.01% | 335 |
|
|
2015
Q4 | $11K | Hold |
95
| – | – | ﹤0.01% | 327 |
|
|
2015
Q3 | $10K | Buy |
+95
| New | +$11.8K | ﹤0.01% | 326 |
|
|
2014
Q3 | – | Sell |
-800
| Closed | -$112K | – | 487 |
|
|
2014
Q2 | $112K | Buy |
+800
| New | +$60.8K | 0.04% | 130 |
|
Other funds holding CELG
MCF Advisors's CELG Position: Q4 2019 in Review
MCF Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 100 shares — an estimated $10K sold.
MCF Advisors first reported a position in CELG in Q2 2014 and held it in 18 quarters. The position peaked at $112K in Q2 2014. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- MCF Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- MCF Advisors sold 100 Celgene Corp shares in Q4 2019, an estimated $10K.
- MCF Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 18 quarters.
- MCF Advisors's Celgene Corp position peaked at $112K in Q2 2014.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on MCF Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.